# Lithium Carbonate

NDC: 0615-8480
Generic name: Lithium Carbonate
Labeler / Manufacturer: NCS HealthCare of KY, LLC dba Vangard Labs
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20090203

FDA application: ANDA079139

## Active ingredients

- LITHIUM CARBONATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0615-8480"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0615-8480
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=204d94de-83e4-400e-bd6b-70b49813802c